NeoGenomics Inc. (NASDAQ: NEO) flaunted slowness of -4.39% at $8.05, as the Stock market unbolted on June 01, 2022. During the day, the stock rose to $8.665 and sunk to $7.91 before settling in for the price of $8.42 at the close. Taking a more long-term approach, NEO posted a 52-week range of $7.26-$54.74.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 15.90%. Meanwhile, its Annual Earning per share during the time was 29.40%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -286.40%. This publicly-traded company’s shares outstanding now amounts to $123.63 million, simultaneously with a float of $121.06 million. The organization now has a market capitalization sitting at $929.78 million. At the time of writing, stock’s 50-day Moving Average stood at $11.11, while the 200-day Moving Average is $28.88.
If we measure the efficiency of the company that is accounted for 2000 employees. For the Profitability, stocks gross margin was +37.08, operating margin was -19.66 and Pretax Margin of -3.11.
NeoGenomics Inc. (NEO) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the NeoGenomics Inc. industry. NeoGenomics Inc.’s current insider ownership accounts for 1.10%, in contrast to 91.90% institutional ownership. According to the most recent insider trade that took place on Mar 07, this organization’s Chief Financial Officer sold 3,209 shares at the rate of 18.29, making the entire transaction reach 58,693 in total value, affecting insider ownership by 98,516. Preceding that transaction, on Dec 21, Company’s Chief Financial Officer sold 1,846 for 35.00, making the whole transaction’s value amount to 64,610. This particular insider is now the holder of 11,689 in total.
NeoGenomics Inc. (NEO) Earnings and Revenue Records
Going through the last 3-months fiscal report unveiled on the 3/30/2022, it has been observed that the corporation posted -$0.2 earnings per share (EPS) during the time that was better the consensus figure (set at -$0.23) by $0.03. This company achieved a net margin of -1.72 while generating a return on equity of -0.93. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.
NeoGenomics Inc.’s EPS decrease for this current 12-month fiscal period is -286.40% and is forecasted to reach -0.54 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 1.30% through the next 5 years, which can be compared against the 29.40% growth it accomplished over the previous five years trading on the market.
NeoGenomics Inc. (NASDAQ: NEO) Trading Performance Indicators
Let’s observe the current performance indicators for NeoGenomics Inc. (NEO). It’s Quick Ratio in the last reported quarter now stands at 7.60. The Stock has managed to achieve an average true range (ATR) of 0.79. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.91.
In the same vein, NEO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.33, a figure that is expected to reach -0.22 in the next quarter, and analysts are predicting that it will be -0.54 at the market close of one year from today.
Technical Analysis of NeoGenomics Inc. (NEO)
Now, what If we examine the latest scores posted by [NeoGenomics Inc., NEO]. During the last 5-days, its volume was lower the volume of 1.91 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 50.48% While, its Average True Range was 0.78.
Raw Stochastic average of NeoGenomics Inc. (NEO) in the period of the previous 100 days is set at 3.54%, which indicates a major fall in contrast to 30.62% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 118.62% that was higher than 105.09% volatility it exhibited in the past 100-days period.